Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liffert Vogt

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 13, 2018
Potassium: poison or panacea in chronic kidney disease?Stanley M H Yeung, Liffert Vogt, Joris I Rotmans, et al.
Clinical Kidney Journal|April 14, 2025
Identifying a cohort of hospitalized chronic kidney disease patients using electronic health records: lessons learnt and implications for future research and clinical practice guidelinesDaniel Fernández-Llaneza, Luuk B Hilbrands, Liffert Vogt, et al.
Frontiers in Genetics|January 11, 2020
Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown EtiologyAmber de Haan, Mark Eijgelsheim, Liffert Vogt, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 21, 2020
Long-term potassium intake and associated renal and cardiovascular outcomes in the clinical settingRik H G Olde Engberink, Bert-Jan H van den Born, Hessel Peters-Sengers, et al.
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes MellitusDidier Collard, Tom F Brouwer, Ron J G Peters, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
Kidney International|January 31, 2017
Quantification of nonosmotic sodium storage capacity following acute hypertonic saline infusion in healthy individualsRik H G Olde Engberink, Nienke M G Rorije, Bert-Jan H van den Born, et al.
Nephron|June 20, 2021
Effects of Tissue Sodium Storage on Plasma Sodium Concentration in Response to Hypo- and Hypertonic StimuliRosa D Wouda, Rik H G Olde Engberink, Eliane F E Wenstedt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatmentLiffert Vogt, Gozewijn D Laverman, Arie van Tol, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 13, 2018
Potassium: poison or panacea in chronic kidney disease?Stanley M H Yeung, Liffert Vogt, Joris I Rotmans, et al.
Clinical Kidney Journal|April 14, 2025
Identifying a cohort of hospitalized chronic kidney disease patients using electronic health records: lessons learnt and implications for future research and clinical practice guidelinesDaniel Fernández-Llaneza, Luuk B Hilbrands, Liffert Vogt, et al.
Frontiers in Genetics|January 11, 2020
Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown EtiologyAmber de Haan, Mark Eijgelsheim, Liffert Vogt, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 21, 2020
Long-term potassium intake and associated renal and cardiovascular outcomes in the clinical settingRik H G Olde Engberink, Bert-Jan H van den Born, Hessel Peters-Sengers, et al.
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes MellitusDidier Collard, Tom F Brouwer, Ron J G Peters, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
Kidney International|January 31, 2017
Quantification of nonosmotic sodium storage capacity following acute hypertonic saline infusion in healthy individualsRik H G Olde Engberink, Nienke M G Rorije, Bert-Jan H van den Born, et al.
Nephron|June 20, 2021
Effects of Tissue Sodium Storage on Plasma Sodium Concentration in Response to Hypo- and Hypertonic StimuliRosa D Wouda, Rik H G Olde Engberink, Eliane F E Wenstedt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatmentLiffert Vogt, Gozewijn D Laverman, Arie van Tol, et al.
Pageof 20